Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Farhat Nasim

Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Farhat Nasim

Articles By : Farhat Nasim

Over 4000 medical device manufacturing sites licensed since 2021, Minister tells Parliament

Union Budget 2025 Disappoints Medical Devices Industry, No Relief for Import Dependency: AiMed

Farhat Nasim1 Feb 2025 3:05 PM IST

New Delhi: The Union Budget 2025 has laid out a strong macro-economic and policy direction, but it has left the medical devices industry disheartened...

Lupin secures SBTi validation for emission reduction targets

Lupin's Generic Entresto Approved by USFDA, Set to Rival Novartis' Bestseller

Farhat Nasim29 Jan 2025 8:04 PM IST

Mumbai: In a fresh challenge to Novartis' blockbuster heart failure drug Entresto, Indian generics maker Lupin has received approval from the U.S....

NPPA Warns Drugmakers Against Arbitrary Pricing, Calls for MRP Uniformity

Drug Price Transparency: Committee Asks NPPA To Rollout PMRU In Remaining States, UTs

Farhat Nasim28 Jan 2025 7:04 PM IST

New Delhi: The National Pharmaceutical Pricing Authority (NPPA) has been asked by the Parliamentary Standing Committee on Chemicals and Fertilisers to...

No Eligible Successor: Centre Clarifies DCGIs Contractual Reappointment

Dr Raghuvanshi To Continue as DCGI Amidst Search For Successor, 18 Candidates Vie For Top Post

Farhat Nasim25 Jan 2025 6:28 PM IST

New Delhi: As the government continues its search for a new Drugs Controller General of India (DCGI), it has decided to extend the tenure of the...

Corporate Chaos: Glenmark Faces Backlash Over Abrupt Job Cuts

Farhat Nasim24 Jan 2025 5:31 PM IST

New Delhi: Enraged after the alleged abrupt layoff citing redundancy, hundreds of employees of Glenmark Pharmaceuticals' Consumer Care Division, which...

Sun Pharma, Zydus and 3 others recall products in US

Zydus Lifesciences Dapsone Gel Recalled by USFDA

Farhat Nasim23 Jan 2025 7:49 PM IST

New Delhi: Zydus Lifesciences Ltd has been implicated in a recall of 23,304 bottles of Dapsone Gel 7.5%, a popular acne treatment distributed under...

NPPA Committee Caps Price of Akums Cetirizine Eye Drops at Rs 14.42 per ml

NPPA Directs Drug Makers to Submit Data for Ceiling Prices of Lohexol, IV Fluids

Farhat Nasim23 Jan 2025 7:46 PM IST

New Delhi: The National Pharmaceuticals Pricing Authority (NPPA) has sought certain data from concerned drug manufacturers and marketing...

Last Chance: PCI Extends Deadline for 2025-26 Academic Year Approvals

Farhat Nasim22 Jan 2025 6:07 PM IST

New Delhi: The Pharmacy Council of India (PCI) has extended the deadline for institutions to submit their Standard Inspection Format (SIF)...

Abuse of the Process of Law: Delhi HC Upholds Dismissal of Complaint Against Hospital, Doctor Accused of Medical Negligence

Macleods Pharma Wins Legal Battle Over Linagliptin Patent

Farhat Nasim21 Jan 2025 5:41 PM IST

New Delhi: In a major setback to Boehringer Ingelheim, the Delhi High Court has upheld the maintainability of a revocation petition filed by...

USFDA Flags Sarfez Pharma for Misleading Promotion of Torsemide Drug Soaanz

USFDA Warns of Mix-Ups After Reports of Wrong Epinephrine Injections

Farhat Nasim18 Jan 2025 8:32 PM IST

New Delhi: The United States Food and Drug Administration (USFDA) issued a critical warning to health care professionals about the risks...

Gujarat HC Halts DGGI Action on Rs 56.33 Cr GST Demand Against Zydus Unit

GST Breakthrough: Gene Therapy Becomes Tax-Free

Farhat Nasim18 Jan 2025 8:29 PM IST

New Delhi: Patients battling cancer and rare diseases are expected to take a sigh of relief as the Government of India has exempted gene therapy...

Adverse drug reactions from normal saline: Punjab imposes 3-year ban on Captab Biotech

Government Bans Import of Refurbished Medical Devices

Farhat Nasim17 Jan 2025 6:44 PM IST

New Delhi: The Central Drugs Standard Control Organisation (CDSCO) has issued a directive to halt the import of refurbished medical devices, citing...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok